ULTACAN

ANDA

ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE | A201751 | HANSAMED INC

1 strength0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jul 13, 2017	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 4%;EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML)

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Jul 11, 2017

No patent or exclusivity listings for this strength.